上流バイオプロセスの世界市場レポート 2025年

上流バイオプロセスの市場規模は今後数年で急成長が見込まれます。2029年にはCAGR13.2％で224億3,000万米ドルに成長します。予測期間の成長は、シングルユースバイオリアクタの商業利用、バイオ医薬品製造のアウトソーシング、製薬およびバイオテクノロジー産業の急成長、シングルユース上流バイオプロセスの採用増加、パートナーシップ、合併、買収、コラボレーションの増加に起因しています。予測期間における主な動向としては、バイオ医薬品業界における研究開発投資の増加、技術の進歩、高度な上流バイオプロセス技術、新技術の開発、高度なろ過技術などが挙げられます。

上流バイオプロセス市場の成長は、バイオ医薬品製造のアウトソーシングによって促進されると予想されます。このアウトソーシングは、製造受託機関（CMO）や開発・製造受託機関（CDMO）のような外部の事業体に特定の製造段階を委託するものです。アウトソーシングの背景には、コスト効率、コアコンピタンスへの集中、生産規模の柔軟性、専門知識へのアクセス、リスクの軽減といった要因があります。バイオ医薬品製造のアウトソーシングは、外部の専門知識を活用し、業務を合理化し、コストを削減することで、製品開発を加速させる。例えば、BDO USAは、2025年までに開発・製造受託企業とハイブリッド製造企業が、世界の哺乳類生産能力（約7,500kL）の44％を支配するようになると予測しています。したがって、バイオ医薬品製造のアウトソーシングは、上流バイオプロセス市場の成長の主要な促進要因となっています。

上流バイオプロセス市場の主要企業は、細胞培養プロセスに合わせた高度なバイオリアクターの開発に注力し、性能、柔軟性、拡張性を高めています。バイオリアクターは上流バイオプロセスにおいて極めて重要なツールであり、細胞培養や生体分子製造を通じて効率的かつ制御されたバイオ医薬品生産を可能にします。例えば、2023年4月、Cytiva社は、シングルユースの上流バイオプロセス手順を合理化するために設計されたX-platformバイオリアクターを発表しました。これらのバイオリアクターは、タンク、キャビネットアセンブリ、ヒューマン・マシン・インターフェース（HMI）で構成されるモジュラーデザインを特徴としており、カスタムハードウェアやシングルユースバッグを必要とせずに柔軟なアレンジが可能です。ユーザーフレンドリーな特徴として、フルオープンドア、バッフル、改良されたケーブルマネジメントを備えた最適化された容器があります。さらに、オンラインBioreactor Scalerツールは、スケールアップを成功させるための最適なパラメーターを決定するのに役立ちます。

目次

第1章 エグゼクティブサマリー

第2章 市場の特徴

第3章 市場動向と戦略

第4章 市場- 金利、インフレ、地政学、新型コロナウイルス感染症、そして景気回復が市場に与える影響を含むマクロ経済シナリオ

第5章 世界の成長分析と戦略分析フレームワーク

• 世界上流バイオプロセス PESTEL分析（政治、社会、技術、環境、法的要因、促進要因と抑制要因）
• 最終用途産業の分析
• 世界の上流バイオプロセス市場：成長率分析
• 世界の上流バイオプロセス市場の実績：規模と成長, 2019-2024
• 世界の上流バイオプロセス市場の予測：規模と成長, 2024-2029, 2034F
• 世界上流バイオプロセス総アドレス可能市場（TAM）

第6章 市場セグメンテーション

• 世界の上流バイオプロセス市場：製品タイプ別、実績と予測, 2019-2024, 2024-2029F, 2034F
• バイオリアクター
• 発酵槽
• 細胞培養培地
• フィルター
• バッグと容器
• 世界の上流バイオプロセス市場：ワークフロー別、実績と予測, 2019-2024, 2024-2029F, 2034F
• メディアの準備
• 細胞培養
• 細胞分離
• 世界の上流バイオプロセス市場使用タイプ別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 使い捨て
• 多目的
• 世界の上流バイオプロセス市場モード別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 社内
• アウトソーシング
• 世界の上流バイオプロセス市場：エンドユーザー別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 受託開発製造機関（CDMO）または受託調査機関（CRO）
• 調査・学術機関
• バイオ医薬品企業
• 世界の上流バイオプロセス市場、バイオリアクターのサブセグメンテーション、タイプ別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 使い捨てバイオリアクター
• 多目的バイオリアクター
• 世界の上流バイオプロセス市場、発酵槽のサブセグメンテーション、タイプ別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 実験室用発酵槽
• パイロットスケール発酵槽
• 工業用発酵槽
• 世界の上流バイオプロセス市場細胞培養培地の種類別サブセグメンテーション、実績と予測, 2019-2024, 2024-2029F, 2034F
• 粉末培地
• 液体培地
• 世界の上流バイオプロセス市場、フィルターのサブセグメンテーション、タイプ別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 滅菌フィルター
• エアフィルター
• カプセルフィルター
• 世界の上流バイオプロセス市場バッグと容器の種類別サブセグメンテーション、実績と予測, 2019-2024, 2024-2029F, 2034F
• 使い捨てバッグ
• バイオプロセスコンテナ
• 収納バッグ

第7章 地域別・国別分析

• 世界の上流バイオプロセス市場：地域別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 世界の上流バイオプロセス市場：国別、実績と予測, 2019-2024, 2024-2029F, 2034F

第8章 アジア太平洋市場

第9章 中国市場

第10章 インド市場

第11章 日本市場

第12章 オーストラリア市場

第13章 インドネシア市場

第14章 韓国市場

第15章 西欧市場

第16章 英国市場

第17章 ドイツ市場

第18章 フランス市場

第19章 イタリア市場

第20章 スペイン市場

第21章 東欧市場

第22章 ロシア市場

第23章 北米市場

第24章 米国市場

第25章 カナダ市場

第26章 南米市場

第27章 ブラジル市場

第28章 中東市場

第29章 アフリカ市場

第30章 競合情勢と企業プロファイル

• 上流バイオプロセス市場：競合情勢
• 上流バイオプロセス市場：企業プロファイル
  • Thermo Fisher Scientific Inc. Overview, Products and Services, Strategy and Financial Analysis
  • Danaher Corp Overview, Products and Services, Strategy and Financial Analysis
  • Merck KGaA Overview, Products and Services, Strategy and Financial Analysis
  • GE HealthCare Technologies Overview, Products and Services, Strategy and Financial Analysis
  • Parker Hannifin Corp Overview, Products and Services, Strategy and Financial Analysis

第31章 その他の大手企業と革新的企業

• Corning Inc.
• AGC Biologics
• Avantor
• AGC Inc.
• Boehringer Ingelheim International GmbH
• Catalent Inc.
• Sartorius AG
• Entegris Inc.
• Getinge AB
• Bio-Rad Laboratories Inc.
• Samsung Biologics Co. Ltd.
• Eppendorf AG
• Repligen Corporation
• Takara Bio Inc.
• KBI Biopharma Inc.

第32章 世界の市場競合ベンチマーキングとダッシュボード

第33章 主要な合併と買収

第34章 最近の市場動向

第35章 市場の潜在力が高い国、セグメント、戦略

• 上流バイオプロセス市場2029：新たな機会を提供する国
• 上流バイオプロセス市場2029：新たな機会を提供するセグメント
• 上流バイオプロセス市場2029：成長戦略
  • 市場動向に基づく戦略
  • 競合の戦略

第36章 付録

Upstream bioprocessing involves preparing and cultivating cells to produce biological products such as proteins and vaccines. It focuses on cell line development and cell culture to create a scalable system that maximizes yield and quality, ensuring reproducibility and efficiency for downstream purification and formulation.

The primary products of upstream bioprocessing include bioreactors, fermenters, cell culture media, filters, and bags and containers. Bioreactors are vessels or tanks where biological reactions and processes occur under controlled conditions. The workflow includes media preparation, cell culture, and cell separation, with usage options including single-use and multi-use systems. These processes can be performed in-house or outsourced by various end users such as contract development and manufacturing organizations (CDMOs), contract research organizations (CROs), research and academic institutes, and biopharmaceutical companies.

The upstream bioprocessing market research report is one of a series of new reports from The Business Research Company that provides upstream bioprocessing market statistics, including upstream bioprocessing industry global market size, regional shares, competitors with a upstream bioprocessing market share, detailed upstream bioprocessing market segments, market trends and opportunities, and any further data you may need to thrive in the upstream bioprocessing industry. This upstream bioprocessing market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The upstream bioprocessing market size has grown rapidly in recent years. It will grow from $12.03 billion in 2024 to $13.66 billion in 2025 at a compound annual growth rate (CAGR) of 13.6%. The growth in the historic period can be attributed to rise in need for process optimization and contamination free, safe and efficient production of biomolecules, commercial success and rising demand for bio-therapeutics, rise in the implementation of process analytical technology, rise in chronic disease prevalence, and increased research into the production of biosimilar.

The upstream bioprocessing market size is expected to see rapid growth in the next few years. It will grow to $22.43 billion in 2029 at a compound annual growth rate (CAGR) of 13.2%. The growth in the forecast period can be attributed to commercial use of single-use bioreactors, outsourcing of biopharmaceutical manufacturing, rapid growth of pharmaceutical and biotechnology industries, rising adoption of single-use upstream bioprocessing, and increasing partnerships, mergers, acquisitions, and collaborations. Major trends in the forecast period include increasing investments in R&D in biopharmaceutical industry, technological advancements, advanced upstream bioprocessing technologies, development of new technologies and advanced filtration technologies.

The growth of the upstream bioprocessing market is expected to be propelled by the outsourcing of biopharmaceutical manufacturing. This outsourcing involves delegating certain production stages to external entities such as contract manufacturing organizations (CMOs) or contract development and manufacturing organizations (CDMOs). It is driven by factors such as cost efficiency, focus on core competencies, flexibility in production scaling, access to specialized expertise, and risk mitigation. Outsourcing biopharmaceutical manufacturing accelerates product development by leveraging external expertise, streamlining operations, and reducing costs. For instance, BDO USA predicts that by 2025, contract development and manufacturing organizations along with hybrid manufacturing companies will control 44% of the global mammalian capacity of around 7,500kL. Hence, the outsourcing of biopharmaceutical manufacturing is a key driver of the upstream bioprocessing market's growth.

Leading companies in the upstream bioprocessing market are concentrating on developing advanced bioreactors tailored to cell culture processes, enhancing performance, flexibility, and scalability. Bioreactors are crucial tools in upstream bioprocessing, enabling efficient and controlled biopharmaceutical production through cell culture and biomolecule manufacturing. For example, in April 2023, Cytiva introduced X-platform bioreactors designed to streamline single-use upstream bioprocessing procedures. These bioreactors feature a modular design consisting of a tank, cabinet assembly, and human-machine interface (HMI), allowing flexible arrangements without the need for custom hardware or single-use bags. User-friendly features include an optimized vessel with a full-opening door, baffles, and improved cable management. Additionally, the online Bioreactor Scaler tool aids in determining optimal parameters for successful scale-up.

In May 2022, Lonza entered into a license agreement with Adva Biotechnology, granting Adva access to key intellectual property for the global expansion of automated bioreactors. This agreement provides Adva Biotechnology with a non-exclusive license to specific patents in Lonza's portfolio related to smart automation and bioreactor control. Adva Biotechnology, based in Israel, is focused on developing innovative technologies for upstream bioprocessing in the cell therapy industry.

Major companies operating in the upstream bioprocessing market are Thermo Fisher Scientific Inc., Danaher Corp, Merck KGaA, GE HealthCare Technologies, Parker Hannifin Corp, Corning Inc., AGC Biologics, Avantor, AGC Inc., Boehringer Ingelheim International GmbH, Catalent Inc., Sartorius AG, Entegris Inc., Getinge AB, Bio-Rad Laboratories Inc., Samsung Biologics Co. Ltd., Eppendorf AG, Repligen Corporation, Takara Bio Inc., KBI Biopharma Inc., Rentschler Biopharma SE, Just Biotherapeutics Inc., PBS Biotech Inc., Stobbe Group, Applikon Biotechnology

North America was the largest region in the upstream bioprocessing market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the upstream bioprocessing market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

The countries covered in the upstream bioprocessing market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain

The upstream bioprocessing market consists of revenues earned by entities by providing services such as cell line development, inoculum preparation, process development and optimization, scale-up production, quality control and monitoring and raw material supply and management. The market value includes the value of related goods sold by the service provider or included within the service offering. The upstream bioprocessing market also includes sales of recombinant proteins, monoclonal antibodies, vaccines, gene therapy vectors, cell therapy products, enzymes, peptides, bio therapeutics and biosimilars. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Upstream Bioprocessing Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on upstream bioprocessing market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

• Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
• Assess the impact of key macro factors such as conflict, pandemic and recovery, inflation and interest rate environment and the 2nd Trump presidency.
• Create regional and country strategies on the basis of local data and analysis.
• Identify growth segments for investment.
• Outperform competitors using forecast data and the drivers and trends shaping the market.
• Understand customers based on the latest market shares.
• Benchmark performance against key competitors.
• Suitable for supporting your internal and external presentations with reliable high quality data and analysis
• Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
• All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for upstream bioprocessing ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The upstream bioprocessing market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

• The market characteristics section of the report defines and explains the market.
• The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
• The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.

• Market segmentations break down the market into sub markets.
• The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
• The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
• The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

• Markets Covered:1) By Product type: Bioreactors; Fermenters; Cell Culture Media; Filters; Bags And Containers
• 2) By Workflow: Media Preparation; Cell Culture; Cell Separation
• 3) By Usage type: Single-Use; Multi-Use
• 4) By Mode: In House; Outsourced
• 5) By End User: Contract Development and Manufacturing Organization (CDMOs) Or Contract Research Organization (CROs); Research And Academic Institutes; Biopharmaceutical Companies
• Subsegments:
• 1) By Bioreactors: Single-Use Bioreactors; Multi-Use Bioreactors
• 2) By Fermenters: Laboratory Fermenters; Pilot Scale Fermenters; Industrial Fermenters
• 3) By Cell Culture Media: Powdered Media; Liquid Media
• 4) By Filters: Sterile Filters; Air Filters; Capsule Filters
• 5) By Bags And Containers: Single-Use Bags; Bioprocess Containers; Storage Bags
• Companies Mentioned: Thermo Fisher Scientific Inc.; Danaher Corp; Merck KGaA; GE HealthCare Technologies; Parker Hannifin Corp
• Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
• Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
• Time series: Five years historic and ten years forecast.
• Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
• Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
• Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
• Delivery format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Upstream Bioprocessing Market Characteristics

3. Upstream Bioprocessing Market Trends And Strategies

4. Upstream Bioprocessing Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Covid And Recovery On The Market

5. Global Upstream Bioprocessing Growth Analysis And Strategic Analysis Framework

• 5.1. Global Upstream Bioprocessing PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
• 5.2. Analysis Of End Use Industries
• 5.3. Global Upstream Bioprocessing Market Growth Rate Analysis
• 5.4. Global Upstream Bioprocessing Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
• 5.5. Global Upstream Bioprocessing Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
• 5.6. Global Upstream Bioprocessing Total Addressable Market (TAM)

6. Upstream Bioprocessing Market Segmentation

• 6.1. Global Upstream Bioprocessing Market, Segmentation By Product type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Bioreactors
• Fermenters
• Cell Culture Media
• Filters
• Bags And Containers
• 6.2. Global Upstream Bioprocessing Market, Segmentation By Workflow, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Media Preparation
• Cell Culture
• Cell Separation
• 6.3. Global Upstream Bioprocessing Market, Segmentation By Usage type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Single-Use
• Multi-Use
• 6.4. Global Upstream Bioprocessing Market, Segmentation By Mode, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• In House
• Outsourced
• 6.5. Global Upstream Bioprocessing Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Contract Development and Manufacturing Organization (CDMOs) Or Contract Research Organization (CROs)
• Research And Academic Institutes
• Biopharmaceutical Companies
• 6.6. Global Upstream Bioprocessing Market, Sub-Segmentation Of Bioreactors, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Single-Use Bioreactors
• Multi-Use Bioreactors
• 6.7. Global Upstream Bioprocessing Market, Sub-Segmentation Of Fermenters, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Laboratory Fermenters
• Pilot Scale Fermenters
• Industrial Fermenters
• 6.8. Global Upstream Bioprocessing Market, Sub-Segmentation Of Cell Culture Media, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Powdered Media
• Liquid Media
• 6.9. Global Upstream Bioprocessing Market, Sub-Segmentation Of Filters, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Sterile Filters
• Air Filters
• Capsule Filters
• 6.10. Global Upstream Bioprocessing Market, Sub-Segmentation Of Bags And Containers, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Single-Use Bags
• Bioprocess Containers
• Storage Bags

7. Upstream Bioprocessing Market Regional And Country Analysis

• 7.1. Global Upstream Bioprocessing Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 7.2. Global Upstream Bioprocessing Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Upstream Bioprocessing Market

• 8.1. Asia-Pacific Upstream Bioprocessing Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 8.2. Asia-Pacific Upstream Bioprocessing Market, Segmentation By Product type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.3. Asia-Pacific Upstream Bioprocessing Market, Segmentation By Workflow, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.4. Asia-Pacific Upstream Bioprocessing Market, Segmentation By Usage type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Upstream Bioprocessing Market

• 9.1. China Upstream Bioprocessing Market Overview
• 9.2. China Upstream Bioprocessing Market, Segmentation By Product type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.3. China Upstream Bioprocessing Market, Segmentation By Workflow, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.4. China Upstream Bioprocessing Market, Segmentation By Usage type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Upstream Bioprocessing Market

• 10.1. India Upstream Bioprocessing Market, Segmentation By Product type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.2. India Upstream Bioprocessing Market, Segmentation By Workflow, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.3. India Upstream Bioprocessing Market, Segmentation By Usage type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Upstream Bioprocessing Market

• 11.1. Japan Upstream Bioprocessing Market Overview
• 11.2. Japan Upstream Bioprocessing Market, Segmentation By Product type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.3. Japan Upstream Bioprocessing Market, Segmentation By Workflow, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.4. Japan Upstream Bioprocessing Market, Segmentation By Usage type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Upstream Bioprocessing Market

• 12.1. Australia Upstream Bioprocessing Market, Segmentation By Product type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.2. Australia Upstream Bioprocessing Market, Segmentation By Workflow, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.3. Australia Upstream Bioprocessing Market, Segmentation By Usage type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Upstream Bioprocessing Market

• 13.1. Indonesia Upstream Bioprocessing Market, Segmentation By Product type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.2. Indonesia Upstream Bioprocessing Market, Segmentation By Workflow, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.3. Indonesia Upstream Bioprocessing Market, Segmentation By Usage type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Upstream Bioprocessing Market

• 14.1. South Korea Upstream Bioprocessing Market Overview
• 14.2. South Korea Upstream Bioprocessing Market, Segmentation By Product type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.3. South Korea Upstream Bioprocessing Market, Segmentation By Workflow, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.4. South Korea Upstream Bioprocessing Market, Segmentation By Usage type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Upstream Bioprocessing Market

• 15.1. Western Europe Upstream Bioprocessing Market Overview
• 15.2. Western Europe Upstream Bioprocessing Market, Segmentation By Product type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.3. Western Europe Upstream Bioprocessing Market, Segmentation By Workflow, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.4. Western Europe Upstream Bioprocessing Market, Segmentation By Usage type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Upstream Bioprocessing Market

• 16.1. UK Upstream Bioprocessing Market, Segmentation By Product type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.2. UK Upstream Bioprocessing Market, Segmentation By Workflow, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.3. UK Upstream Bioprocessing Market, Segmentation By Usage type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Upstream Bioprocessing Market

• 17.1. Germany Upstream Bioprocessing Market, Segmentation By Product type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.2. Germany Upstream Bioprocessing Market, Segmentation By Workflow, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.3. Germany Upstream Bioprocessing Market, Segmentation By Usage type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Upstream Bioprocessing Market

• 18.1. France Upstream Bioprocessing Market, Segmentation By Product type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.2. France Upstream Bioprocessing Market, Segmentation By Workflow, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.3. France Upstream Bioprocessing Market, Segmentation By Usage type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Upstream Bioprocessing Market

• 19.1. Italy Upstream Bioprocessing Market, Segmentation By Product type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.2. Italy Upstream Bioprocessing Market, Segmentation By Workflow, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.3. Italy Upstream Bioprocessing Market, Segmentation By Usage type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Upstream Bioprocessing Market

• 20.1. Spain Upstream Bioprocessing Market, Segmentation By Product type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.2. Spain Upstream Bioprocessing Market, Segmentation By Workflow, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.3. Spain Upstream Bioprocessing Market, Segmentation By Usage type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Upstream Bioprocessing Market

• 21.1. Eastern Europe Upstream Bioprocessing Market Overview
• 21.2. Eastern Europe Upstream Bioprocessing Market, Segmentation By Product type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.3. Eastern Europe Upstream Bioprocessing Market, Segmentation By Workflow, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.4. Eastern Europe Upstream Bioprocessing Market, Segmentation By Usage type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Upstream Bioprocessing Market

• 22.1. Russia Upstream Bioprocessing Market, Segmentation By Product type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.2. Russia Upstream Bioprocessing Market, Segmentation By Workflow, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.3. Russia Upstream Bioprocessing Market, Segmentation By Usage type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Upstream Bioprocessing Market

• 23.1. North America Upstream Bioprocessing Market Overview
• 23.2. North America Upstream Bioprocessing Market, Segmentation By Product type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.3. North America Upstream Bioprocessing Market, Segmentation By Workflow, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.4. North America Upstream Bioprocessing Market, Segmentation By Usage type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Upstream Bioprocessing Market

• 24.1. USA Upstream Bioprocessing Market Overview
• 24.2. USA Upstream Bioprocessing Market, Segmentation By Product type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.3. USA Upstream Bioprocessing Market, Segmentation By Workflow, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.4. USA Upstream Bioprocessing Market, Segmentation By Usage type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Upstream Bioprocessing Market

• 25.1. Canada Upstream Bioprocessing Market Overview
• 25.2. Canada Upstream Bioprocessing Market, Segmentation By Product type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.3. Canada Upstream Bioprocessing Market, Segmentation By Workflow, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.4. Canada Upstream Bioprocessing Market, Segmentation By Usage type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Upstream Bioprocessing Market

• 26.1. South America Upstream Bioprocessing Market Overview
• 26.2. South America Upstream Bioprocessing Market, Segmentation By Product type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.3. South America Upstream Bioprocessing Market, Segmentation By Workflow, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.4. South America Upstream Bioprocessing Market, Segmentation By Usage type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Upstream Bioprocessing Market

• 27.1. Brazil Upstream Bioprocessing Market, Segmentation By Product type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.2. Brazil Upstream Bioprocessing Market, Segmentation By Workflow, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.3. Brazil Upstream Bioprocessing Market, Segmentation By Usage type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Upstream Bioprocessing Market

• 28.1. Middle East Upstream Bioprocessing Market Overview
• 28.2. Middle East Upstream Bioprocessing Market, Segmentation By Product type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.3. Middle East Upstream Bioprocessing Market, Segmentation By Workflow, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.4. Middle East Upstream Bioprocessing Market, Segmentation By Usage type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Upstream Bioprocessing Market

• 29.1. Africa Upstream Bioprocessing Market Overview
• 29.2. Africa Upstream Bioprocessing Market, Segmentation By Product type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.3. Africa Upstream Bioprocessing Market, Segmentation By Workflow, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.4. Africa Upstream Bioprocessing Market, Segmentation By Usage type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Upstream Bioprocessing Market Competitive Landscape And Company Profiles

• 30.1. Upstream Bioprocessing Market Competitive Landscape
• 30.2. Upstream Bioprocessing Market Company Profiles
  • 30.2.1. Thermo Fisher Scientific Inc. Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.2. Danaher Corp Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.3. Merck KGaA Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.4. GE HealthCare Technologies Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.5. Parker Hannifin Corp Overview, Products and Services, Strategy and Financial Analysis

31. Upstream Bioprocessing Market Other Major And Innovative Companies

• 31.1. Corning Inc.
• 31.2. AGC Biologics
• 31.3. Avantor
• 31.4. AGC Inc.
• 31.5. Boehringer Ingelheim International GmbH
• 31.6. Catalent Inc.
• 31.7. Sartorius AG
• 31.8. Entegris Inc.
• 31.9. Getinge AB
• 31.10. Bio-Rad Laboratories Inc.
• 31.11. Samsung Biologics Co. Ltd.
• 31.12. Eppendorf AG
• 31.13. Repligen Corporation
• 31.14. Takara Bio Inc.
• 31.15. KBI Biopharma Inc.

32. Global Upstream Bioprocessing Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Upstream Bioprocessing Market

34. Recent Developments In The Upstream Bioprocessing Market

35. Upstream Bioprocessing Market High Potential Countries, Segments and Strategies

• 35.1 Upstream Bioprocessing Market In 2029 - Countries Offering Most New Opportunities
• 35.2 Upstream Bioprocessing Market In 2029 - Segments Offering Most New Opportunities
• 35.3 Upstream Bioprocessing Market In 2029 - Growth Strategies
  • 35.3.1 Market Trend Based Strategies
  • 35.3.2 Competitor Strategies

36. Appendix

• 36.1. Abbreviations
• 36.2. Currencies
• 36.3. Historic And Forecast Inflation Rates
• 36.4. Research Inquiries
• 36.5. The Business Research Company
• 36.6. Copyright And Disclaimer